Serum Selenium Status in Graves' Disease and Hashimoto's Thyroiditis in an Iodine-sufficient Area: A Case-control Study

Overview

Journal J Res Med Sci

Specialty General Medicine

Date 2023 Jan 23

PMID 36685028

Authors

Zahra Heidari

Vahid Sheikhi

Affiliations

Soon will be listed here.

Abstract

Background: Selenium (Se) can be found in the molecular structure of selenoproteins; including thioredoxin reductase and glutathione peroxidase and also in Type I and II deiodinases. Previous studies have shown that Se deficiency has been linked to autoimmune thyroid disease (AITD). In the present study, we investigated the serum Se levels of patients with Graves' disease (GD), Hashimoto's thyroiditis (HT), and euthyroid individuals as a control group.

Materials And Methods: The present study was performed on patients with newly diagnosed AITD (GD and HT). The control group was matched with the case group in terms of parameters such as age and sex. Free thyroxine, free triiodothyronine, thyroid-stimulating hormone, antithyroid peroxidase, antithyroglobulin, and serum Se levels were measured in all participants. These parameters were compared between groups.

Results: Data from 132 patients with HT, 120 patients with GD, and 120 healthy euthyroid patients as a control group were analyzed. The Se level in patients with HT (104.36 μg/l) and GD (97.68 μg/l) was significantly lower than in the control group (122.63 μg/l) ( < 0.001). The incidence of Se deficiency in patients with HT, GD, and in the control group was 15.2%, 2.5%, and 2.5%, respectively ( < 0.001). In patients with GD, 34 patients (28.33%) had Graves' orbitopathy. Se levels in patients with orbitopathy were significantly lower than in patients without orbitopathy.

Conclusion: The serum Se level was significantly lower in newly diagnosed patients with GD and HT than in the control group. Overall, Se deficiency can be considered a risk factor for AITDs.

Citing Articles

Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases-A Literature Review.

Brylinski L, Kostelecka K, Wolinski F, Komar O, Milosz A, Michalczyk J Nutrients. 2025; 17(3).

PMID: 39940256 PMC: 11819802. DOI: 10.3390/nu17030398.

Analysis of risk factors for autoimmune thyroid disease based on blood indicators and urinary iodine concentrations.

Liu J, Feng Z, Gao R, Liu P, Meng F, Fan L Front Endocrinol (Lausanne). 2024; 15:1453828.

PMID: 39583966 PMC: 11581849. DOI: 10.3389/fendo.2024.1453828.

Selenium Status Associates with Thyroid Hormone and Thyroid Dysfunction in Older Chinese Adults.

Li F, Su L, Shao R, Luo J, Chen Y, Huang Y Biol Trace Elem Res. 2024; 203(3):1413-1421.

PMID: 38907121 DOI: 10.1007/s12011-024-04286-2.

Autoimmunity, New Potential Biomarkers and the Thyroid Gland-The Perspective of Hashimoto's Thyroiditis and Its Treatment.

Tywanek E, Michalak A, Swirska J, Zwolak A Int J Mol Sci. 2024; 25(9).

PMID: 38731922 PMC: 11083198. DOI: 10.3390/ijms25094703.

References

Nordio M, Pajalich R . Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. J Thyroid Res. 2013; 2013:424163. PMC: 3809375. DOI: 10.1155/2013/424163. View

Kratzsch J, Fiedler G, Leichtle A, Brugel M, Buchbinder S, Otto L . New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem. 2005; 51(8):1480-6. DOI: 10.1373/clinchem.2004.047399. View

NICHOL C, Herdman J, Sattar N, ODwyer P, St J OReilly D, Littlejohn D . Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response?. Clin Chem. 1998; 44(8 Pt 1):1764-6. View

Delshad H, Azizi F . Review of Iodine Nutrition in Iranian Population in the Past Quarter of Century. Int J Endocrinol Metab. 2018; 15(4):e57758. PMC: 5903391. DOI: 10.5812/ijem.57758. View

Brent G . Clinical practice. Graves' disease. N Engl J Med. 2008; 358(24):2594-605. DOI: 10.1056/NEJMcp0801880. View

Navarro-Alarcon M, Cabrera-Vique C . Selenium in food and the human body: a review. Sci Total Environ. 2008; 400(1-3):115-41. DOI: 10.1016/j.scitotenv.2008.06.024. View

Vasiliu I, Preda C, Serban I, Strungaru S, Nicoara M, Plavan G . SELENIUM STATUS IN AUTOIMMUNE THYROIDITIS. Rev Med Chir Soc Med Nat Iasi. 2016; 119(4):1037-44. View

Effraimidis G, Wiersinga W . Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014; 170(6):R241-52. DOI: 10.1530/EJE-14-0047. View

Duntas L . Environmental factors and thyroid autoimmunity. Ann Endocrinol (Paris). 2011; 72(2):108-13. DOI: 10.1016/j.ando.2011.03.019. View

10.

Bulow Pedersen I, Knudsen N, Carle A, Schomburg L, Kohrle J, Jorgensen T . Serum selenium is low in newly diagnosed Graves' disease: a population-based study. Clin Endocrinol (Oxf). 2013; 79(4):584-90. DOI: 10.1111/cen.12185. View

11.

Wu Q, Rayman M, Lv H, Schomburg L, Cui B, Gao C . Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease. J Clin Endocrinol Metab. 2015; 100(11):4037-47. DOI: 10.1210/jc.2015-2222. View

12.

Sturniolo G, Mesa J . Selenium supplementation and autoimmune thyroid diseases. Endocrinol Nutr. 2013; 60(8):423-6. DOI: 10.1016/j.endonu.2013.07.001. View

13.

Rayman M . Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc Nutr Soc. 2018; 78(1):34-44. DOI: 10.1017/S0029665118001192. View

14.

Kucharzewski M, Braziewicz J, Majewska U, Gozdz S . Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res. 2002; 88(1):25-30. DOI: 10.1385/BTER:88:1:25. View

15.

Johnson C, Fordyce F, Rayman M . Symposium on 'Geographical and geological influences on nutrition': Factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc Nutr Soc. 2009; 69(1):119-32. DOI: 10.1017/S0029665109991807. View

16.

Wimmer I, Hartmann T, Brustbauer R, Minear G, Dam K . Selenium levels in patients with autoimmune thyroiditis and controls in lower Austria. Horm Metab Res. 2014; 46(10):707-9. DOI: 10.1055/s-0034-1377029. View

17.

Wertenbruch T, Willenberg H, Sagert C, Nguyen T, Bahlo M, Feldkamp J . Serum selenium levels in patients with remission and relapse of graves' disease. Med Chem. 2007; 3(3):281-4. DOI: 10.2174/157340607780620662. View

18.

Duntas L . The evolving role of selenium in the treatment of graves' disease and ophthalmopathy. J Thyroid Res. 2012; 2012:736161. PMC: 3270443. DOI: 10.1155/2012/736161. View

19.

Wang L, Wang B, Chen S, Hou X, Wang X, Zhao S . Effect of Selenium Supplementation on Recurrent Hyperthyroidism Caused by Graves' Disease: A Prospective Pilot Study. Horm Metab Res. 2016; 48(9):559-64. DOI: 10.1055/s-0042-110491. View

20.

Ban Y, Tomer Y . Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev. 2005; 3(1):20-32. View